Levels of insulin autoantibodies (IAA) vary among different first degree relatives of insulin-dependent diabetes mellitus patients, suggesting genetic regulation. We previously reported elevated IAA among DR4-positive at risk relatives. In this study, 72/82 at risk relatives were IAA positive, of whom 75% (54/72) carried DR4 versus 20% (2/10) of IAA-negative relatives (P = 0.0004). However, 69% (18/26) of DR4-negative relatives were IAA positive. Since DR4 did not account for all IAA positivity, we analyzed DQA1 and DQB1 alleles. Homozygosity for DQA1 alleles deriving from the evolutionary lineage 4 (*0401, *0501, *0601) was associated with low IAA levels, while lineage 1-3 alleles (*0101, *0102, *0103, *0201, *0301) correlated with higher levels. Most (93%, 65/70) relatives with lineage 1-3 alleles were IAA positive (mean = 360 +/- 63 SEM nU/ml). Only 7/12 relatives homozygous for lineage 4 alleles were IAA-positive, with lower levels than relatives with lineage 1-3 alleles (mean = 55 +/- 15 SEM nU/ml, P < 0.0001; 7/12 vs 65/70, P = 0.004). The amino acid sequences of lineage 1-3 alleles uniquely share glutamic acid (E) and phenylalanine (F) at positions 40 and 51 (EF alleles). Lineage 4 alleles have glycine (G) and leucine (L) at those positions (GL alleles). 90% (65/72) of IAA-positive relatives had an EF allele, while only 75% (54/72) had DR4 (P = 0.01). Homozygosity for GL alleles (often DQA1 *0501 on DR3 haplotypes) correlated with little or no humoral response to insulin. Thus, HLA-DQB1 GL alleles, or other genes on haplotypes (e.g., DR3) that carry these DQA1 alleles, may confer recessive low responsiveness to insulin.
A Pugliese, T Bugawan, R Moromisato, Z L Awdeh, C A Alper, R A Jackson, H A Erlich, G S Eisenbarth
Title and authors | Publication | Year |
---|---|---|
George S. Eisenbarth: insulin and type 1 diabetes
A Pugliese, JS Skyler |
Diabetes care | 2013 |
Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual β cell function
SA Dib, MB Gomes |
Diabetology & metabolic syndrome | 2009 |
Autoantibodies in type 1 diabetes
CE Taplin, JM Barker |
Autoimmunity | 2008 |
Deleting islet autoimmunity
E Liu, M Li, J Jasinski, M Kobayashi, R Gianani, M Nakayama, GS Eisenbarth |
Cell Biochemistry and Biophysics | 2007 |
Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies
B Franke, TS Galloway, TJ Wilkin |
Diabetes/Metabolism Research and Reviews | 2005 |
Diabetes-related antibodies in adult diabetic patients
A Falorni, A Brozzetti |
Best Practice & Research Clinical Endocrinology & Metabolism | 2005 |
High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR–SSOP–Luminex method in the Japanese population
Y Itoh, N Mizuki, T Shimada, F Azuma, M Itakura, K Kashiwase, E Kikkawa, JK Kulski, M Satake, H Inoko |
Immunogenetics | 2005 |
Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes
D Devendra, J Paronen, H Moriyama, D Miao, GS Eisenbarth, E Liu |
Journal of Autoimmunity | 2004 |
Endocrine autoantibodies
D Devendra, L Yu, GS Eisenbarth |
Clinics in Laboratory Medicine | 2004 |
Relationship between T and B Cell Responses to Proinsulin in Human Type 1 Diabetes
I Durinovic-Belló, N Maisel, M Schlosser, H Kalbacher, M Deeg, T Eiermann, W Karges, BO Boehm |
Annals of the New York Academy of Sciences | 2003 |
Pediatric Diabetes
RK Menon, MA Sperling |
Pediatric Diabetes | 2003 |
Transient Insulin Autoantibody Expression Independent of Development of Diabetes: Comparison of NOD and NOR Strains
N Abiru, L Yu, D Miao, AK Maniatis, E Liu, H Moriyama, GS Eisenbarth |
Journal of Autoimmunity | 2001 |
Inflammatory Bowel Disease
KD Taylor, H Yang, JI Rotter |
Molecular Genetics and Metabolism | 2001 |
Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice
N Abiru, AK Maniatis, L Yu, D Miao, H Moriyama, D Wegmann, GS Eisenbarth |
Diabetes | 2001 |
Time Clustering of High Titre Insulin Autoantibodies (IAA) in the Cord Blood of Infants Born to Non-Diabetic Mothers
TS Galloway, D Fewster, D Crocker, M Noor, TJ Wilkin |
Autoimmunity | 2000 |
Dual Overlapping Peptides Recognized by Insulin Peptide B:9–23 T Cell Receptor AV13S3 T Cell Clones of the NOD Mouse
N Abiru, D Wegmann, E Kawasaki, P Gottlieb, E Simone, GS Eisenbarth |
Journal of Autoimmunity | 2000 |
Genetic Predisposition to IDDM
S Caillat-Zucman, JF Bach |
Clinical Reviews in Allergy & Immunology | 2000 |
Multiple Genes/Multiple Autoantigens Role in Type 1 Diabetes
N Abiru, GS Eisenbarth |
Clinical Reviews in Allergy & Immunology | 2000 |
Autoimmune Diabetes: The Role of T Cells, MHC Molecules and Autoantigens
I Durinovic-Bello |
Autoimmunity | 1998 |
Endocrine Autoimmunity and Associated Conditions
AP Weetman |
1998 | |
Association of the AChRα-subunit Gene (CHRNA), DQA1*0101, and the DR3 Haplotype in Myasthenia Gravis. Evidence for a Three-gene Disease Model in a Subgroup of Patients
F Djabiri, S Caillat-Zucman, P Gajdos, JP Jaı̈s, L Gomez, I Khalil, D Charron, JF Bach, HJ Garchon |
Journal of Autoimmunity | 1997 |
Interferon-α therapy May induce insulin autoantibody development in patients with chronic viral hepatitis
ED Cesare, M Previti, F Russo, S Brancatelli, MC Ingemi, R Scoglio, N Mazzù, D Cucinotta, G Raimondo |
Digestive Diseases and Sciences | 1996 |
Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease
H Yang, DK Vora, SR Targan, H Toyoda, AL Beaudet, JI Rotter |
Gastroenterology | 1995 |
Autoantigens in type 1 diabetes mellitus
F Dotta, E Anastasi, C Tiberti, UD Mario |
Journal of Endocrinological Investigation | 1994 |
Autoantibodies
MH Lessof, SP Asper |
American Heart Journal | 1960 |